Role of empagliflozin in diabetic patient with acute myocardial infarction who undergone percutaneous coronary intervention

21 May 2022 (08:30 - 18:50)

Organised by:

30 More presentations in this session

Presentation thumbnail

Efficacy and safety of sacubitril/valsartan (LCZ696) in reducing adverse cardiovascular events and controlling hypertension among asians: a meta-analysis of randomised controlled trials

Doctor P. Vera Cruz (Quezon, PH)

Abstract Slides

Presentation thumbnail

Recovery of left ventricular ejection fraction in patients treated with sacubitril/valsartan

Doctor J. Mesquita Guimaraes (Coimbra, PT)

Abstract Slides

Presentation thumbnail

Levosimendan bridge to therapy optimization

Doctor C. Moliner-Abos (Barcelona, ES)

Abstract Slides

Presentation thumbnail

ORal anti-coagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the ORIGAMI pilot investigation

Doctor D. D'Amario (Novara, IT)

Abstract Slides

Presentation thumbnail

Beta-blockers and ivabradine titration in HF patients with LV only fusion pacing CRT

Doctor C. Vacarescu (Timisoara, RO)

Abstract Slides

Access the full session

Session thumbnail

Heart Failure ePosters - focus on Pharmacology and other topics

The Event

Event poster

Heart Failure 2022

21 May 2022 08:30 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources